• Home

  • Documents

  • sbiaevents.comsbiaevents.com/files/GCP2018-Agenda.pdf · FDA U.S. FOOD & DRUG ADMINISTRATION...
2

sbiaevents.comsbiaevents.com/files/GCP2018-Agenda.pdf · FDA U.S. FOOD & DRUG ADMINISTRATION FDA & MHRA Good Clinical Practice Workshop: ata Integrity in Global Clinical Trials —

Embed Size (px)

Citation preview

Page 1: sbiaevents.comsbiaevents.com/files/GCP2018-Agenda.pdf · FDA U.S. FOOD & DRUG ADMINISTRATION FDA & MHRA Good Clinical Practice Workshop: ata Integrity in Global Clinical Trials —
Page 2: sbiaevents.comsbiaevents.com/files/GCP2018-Agenda.pdf · FDA U.S. FOOD & DRUG ADMINISTRATION FDA & MHRA Good Clinical Practice Workshop: ata Integrity in Global Clinical Trials —

FDA Compliance Actions Against IRBs and Clinical Investigators

FDA Compliance Actions Against IRBs and Clinical Investigators

Documents
FDA Guidance_cGMP for Clinical Trials

FDA Guidance_cGMP for Clinical Trials

Documents
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qserve Conference 2013)

Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qserve Conference 2013)

Business
Testing Computers Systems for FDA Mhra Compliance Computer Systems Val.ebooKOID

Testing Computers Systems for FDA Mhra Compliance Computer Systems Val.ebooKOID

Documents
FDA Guidance for CMC for Clinical Trials

FDA Guidance for CMC for Clinical Trials

Documents
Title: Contingency legislation to establish MHRA as …...1 Title: Contingency legislation to establish MHRA as a standalone medicines, medical devices and clinical trials regulator

Title: Contingency legislation to establish MHRA as …...1 Title: Contingency legislation to establish MHRA as a standalone medicines, medical devices and clinical trials regulator

Documents
FDA Decisions for Investigational Device Exemption ... · FDA Decisions for Investigational . Device Exemption Clinical Investigations Guidance for Sponsors, Clinical Investigators,

FDA Decisions for Investigational Device Exemption ... · FDA Decisions for Investigational . Device Exemption Clinical Investigations Guidance for Sponsors, Clinical Investigators,

Documents
Weaving the three critical attributes · GCP inspections- Critical finding by MHRA - 2017 1. ... FDA Warning letter- Official message from US FDA to manufacturer or other organization

Weaving the three critical attributes · GCP inspections- Critical finding by MHRA - 2017 1. ... FDA Warning letter- Official message from US FDA to manufacturer or other organization

Documents
FDA Approvals, IND, IDE and Clinical Trials

FDA Approvals, IND, IDE and Clinical Trials

Documents
FDA-NIH EFFORT TO CAPTURE THE GLOBAL CLINICAL …

FDA-NIH EFFORT TO CAPTURE THE GLOBAL CLINICAL …

Documents
FDA Guidance and Clinical Trials

FDA Guidance and Clinical Trials

Technology
Pharmaceutical Guidelines_ISO, FDA, USFDA, ICH, WHO, GMP, MHRA guideline, Validation Protocol, SOPs_ GMP Audit Check List- Filling and Packaging.pdf

Pharmaceutical Guidelines_ISO, FDA, USFDA, ICH, WHO, GMP, MHRA guideline, Validation Protocol, SOPs_ GMP Audit Check List- Filling and Packaging.pdf

Documents
FDA Requirements for Clinical Trials and Market Approval

FDA Requirements for Clinical Trials and Market Approval

Documents
FDA 2013 Clinical Investigator Training Course: FDA Perspective on International Studies

FDA 2013 Clinical Investigator Training Course: FDA Perspective on International Studies

Health & Medicine
FDA Perspective on International Clinical Trials - 01 Ayalew.pdf · FDA Perspective on International Clinical Trials Kassa Ayalew, M.D., M.P.H. Division of Clinical Compliance Evaluation

FDA Perspective on International Clinical Trials - 01 Ayalew.pdf · FDA Perspective on International Clinical Trials Kassa Ayalew, M.D., M.P.H. Division of Clinical Compliance Evaluation

Documents
FDA, Clinical Pharmacology, Regulatory Science · 1 FDA, Clinical Pharmacology, Regulatory Science & Carl Peck, MD UCSF NDA Partners LLC Principles of Clinical Pharmacology NIH, April

FDA, Clinical Pharmacology, Regulatory Science · 1 FDA, Clinical Pharmacology, Regulatory Science & Carl Peck, MD UCSF NDA Partners LLC Principles of Clinical Pharmacology NIH, April

Documents
Expert Clinical Advice – MHRA Medical Devices · Organisation of clinical advice input, resources and leadership 1 The MHRA must take devices as seriously as medicines: Create a

Expert Clinical Advice – MHRA Medical Devices · Organisation of clinical advice input, resources and leadership 1 The MHRA must take devices as seriously as medicines: Create a

Documents
FDA Perspective on International Clinical Trials

FDA Perspective on International Clinical Trials

Documents
FDA Presentation - Society for Clinical Research Sitessitesolutionssummit.com/wp-content/uploads/2014/11/FDA_Moscicki.pdf · FDA Presentation - Society for Clinical ... • Increasing

FDA Presentation - Society for Clinical Research Sitessitesolutionssummit.com/wp-content/uploads/2014/11/FDA_Moscicki.pdf · FDA Presentation - Society for Clinical ... • Increasing

Documents
clinical pharmacology and biopharmaceutics - Accessdata FDA

clinical pharmacology and biopharmaceutics - Accessdata FDA

Documents
FDA 2013 Clinical Investigator Training Course: The Design of Clinical Trials

FDA 2013 Clinical Investigator Training Course: The Design of Clinical Trials

Health & Medicine
Clinical Significance for Quality of Life Endpoints in Clinical Trials FDA/Industry Statistics Workshop Washington, September 16, 2005 FDA/Industry Statistics

Clinical Significance for Quality of Life Endpoints in Clinical Trials FDA/Industry Statistics Workshop Washington, September 16, 2005 FDA/Industry Statistics

Documents
COVID-19 and Clinical Trials: The Medidata Perspective · 1 day ago · Switzerland swissmedic (v2.2 15Jun) Turkey TMMDA (31Mar) U.K. MHRA (21May) North America U.S. FDA (02Jul) Canada

COVID-19 and Clinical Trials: The Medidata Perspective · 1 day ago · Switzerland swissmedic (v2.2 15Jun) Turkey TMMDA (31Mar) U.K. MHRA (21May) North America U.S. FDA (02Jul) Canada

Documents
An FDA Update on Clinical Trial Site Inspections: A View ...sitesolutionssummit.com/wp-content/uploads/2015/10/Podium_An-FDA... · An FDA Update on Clinical Trial Site Inspections:

An FDA Update on Clinical Trial Site Inspections: A View ...sitesolutionssummit.com/wp-content/uploads/2015/10/Podium_An-FDA... · An FDA Update on Clinical Trial Site Inspections:

Documents
FDA 2013 Clinical Investigator Training Course: Investigator Responsibilities-Regulation and Clinical Trials

FDA 2013 Clinical Investigator Training Course: Investigator Responsibilities-Regulation and Clinical Trials

Health & Medicine
Recent Developments in FDA Regulation of Clinical Trials

Recent Developments in FDA Regulation of Clinical Trials

Documents
NIH-FDA Phase 2 and 3 IND/IDE Clinical Trial Protocol ... · PDF fileNIH-FDA Phase 2 and 3 IND/IDE Clinical Trial Protocol Template NIH-FDA Clinical Trial Protocol Template – v1.0

NIH-FDA Phase 2 and 3 IND/IDE Clinical Trial Protocol ... · PDF fileNIH-FDA Phase 2 and 3 IND/IDE Clinical Trial Protocol Template NIH-FDA Clinical Trial Protocol Template – v1.0

Documents
MHRA - Selcia · Certificate No:UK API 27830 Insp GMP 27830/119738-0009 MHRA Regulating Medicines and MedicalDevices ACTIVE SUBSTANCES FOR CLINICAL TRIALS 3. MANUFACTURING OPERATIONS

MHRA - Selcia · Certificate No:UK API 27830 Insp GMP 27830/119738-0009 MHRA Regulating Medicines and MedicalDevices ACTIVE SUBSTANCES FOR CLINICAL TRIALS 3. MANUFACTURING OPERATIONS

Documents
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate

FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate

Health & Medicine
Pharmacovigilance, the MHRA and Yellow Cards Aileen McKenna Senior Clinical Pharmacist

Pharmacovigilance, the MHRA and Yellow Cards Aileen McKenna Senior Clinical Pharmacist

Documents